hyperCORE International is pleased to announce the appointment of two distinguished industry leaders to its executive team, effective immediately.
| LAKE MARY, Fla., Feb. 19, 2024 /PRNewswire/ -- hyperCORE International—a collaborative network of clinical trial sites (including Alcanza Clinical Research) spanning North America—is pleased to announce the appointment of two distinguished industry leaders to its executive team, effective immediately.
Gwen Welty has joined in the role of Executive Director, tasked with leading hyperCORE’s operational endeavors. With extensive experience in the CRO and Site sectors, Ms. Welty’s addition strengthens hyperCORE’s position as it forges alliances with Sponsors and CROs. She welcomes engagement and can be reached at gwelty@hypercoreinternational.com. Joining as an Executive Consultant, Karri Venn will guide hyperCORE’s strategic direction in an industry transitioning from Full-Service Outsourcing (FSO) to Functional Service Providers (FSP). With a notable career in successful site operations, Ms. Venn’s deep understanding of the site landscape will be invaluable as hyperCORE accelerates research through collaboration with industry CRO and Sponsor partners. She invites inquiries at kvenn@hypercoreinternational.com. Founded in 2019, hyperCORE International is a leading super network of highly experienced and esteemed clinical research site/network companies. Renowned as an industry frontrunner, hyperCORE offers Phase I-IV clinical trial services through a network of over 100 active research sites across two continents and five countries. Each alliance partner brings decades of clinical research expertise, collectively contributing to over 7,000 completed studies and the evaluation of thousands of new drugs and treatments in more than 140,000 randomized patients. While operating independently, every partner integrates common functions to optimize business and clinical operations, promoting harmonization and the sharing of best practices. Dedicated to maintaining the highest standards of research excellence, hyperCORE International prioritizes subject safety, data integrity, rapid study startup, competitive enrollment, and exceptional subject retention. Its members have received numerous accolades for their performance, quality, and innovative contributions. About Alcanza Clinical Research Contact:
SOURCE Alcanza Clinical Research |
View original content to download multimedia:
